Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-884P is a human pseudogene corresponding to a genomic sequence similar to the U6 small nuclear RNA (snRNA) gene, but is predicted to be non-functional and does not encode a functional RNA product[1]. U6 snRNA itself is a core non-coding RNA component involved in the spliceosome, which catalyzes pre-mRNA splicing in eukaryotes[3][5]. However, pseudogenes like RNU6-884P are classified as genomic relics of once-functional genes and typically lack any active biological function, promoter activity, or involvement in cellular processes[1][2]. There is no evidence that RNU6-884P is transcribed or serves as a direct therapeutic target, nor are there known associated diseases, biomarkers, or drug interactions for this pseudogene[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 884, pseudogene (RNU6-884P).